Retraction: Withdrawal: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis (Journal of Biological Chemistry (2015) 290 (27090-27100) DOI: 10.1074/jbc.M115.675371);Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis

Journal of Biological Chemistry

Volumn 290, Issue 45, 2015, Pages 27090-27100

  Son, Young Ok ^a   Pratheeshkumar, Poyil ^a   Roy, Ram Vinod ^a   Hitron, John Andrew ^a   Wang, Lei ^a   Divya, Sasidharan Padmaja ^a   Xu, Mei ^b   Luo, Jia ^b   Chen, Gang ^b   Zhang, Zhuo ^a   Shi, Xianglin ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELL DEATH; CHEMICAL ACTIVATION; PATHOLOGY; TISSUE CULTURE;

BIOLOGICAL CHEMISTRY; CANCER CELLS; CELL TRANSFORMATION; ROS GENERATIONS; TUMORIGENESIS;

ARSENIC;

ARSENIC; CATALASE; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P62; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; BCL2L1 PROTEIN, HUMAN; MANGANESE SUPEROXIDE DISMUTASE; NFE2L2 PROTEIN, HUMAN; P62 PROTEIN, HUMAN; PROTEIN BCL X; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; BINDING AFFINITY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL LINE; CHEMICALLY INDUCED; GENE SILENCING; GENETICS; METABOLISM; ONCOGENE; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ANTIOXIDANTS; APOPTOSIS; ARSENIC; AUTOPHAGY; BCL-X PROTEIN; CARCINOGENESIS; CATALASE; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; ONCOGENES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RNA-BINDING PROTEINS; SUPEROXIDE DISMUTASE;

EID: 84946781660     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.W118.005758     Document Type: Erratum

References (26)

1. Edwards, M. R., Johnson, B., Mire, C. E., Xu, W., Shabman, R. S., Speller, L. N., Leung, D. W., Geisbert, T. W., Amarasinghe, G. K., and Basler, C. F. (2014) The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. Cell Rep. 6, 1017-1025.
2. Nezis, I. P., and Stenmark, H. (2012) p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid. Redox Signal. 17, 786-793.
3. Duran, A., Linares, J. F., Galvez, A. S., Wikenheiser, K., Flores, J. M., Diaz- Meco, M. T., and Moscat, J. (2008) The signaling adaptor p62 is an important NF-kB mediator in tumorigenesis. Cancer Cell 13, 343-354.
4. Lau, A., Zheng, Y., Tao, S., Wang, H., Whitman, S. A., White, E., and Zhang, D. D. (2013) Arsenic inhibits autophagic flux, activating the Nrf2- Keap1 pathway in a p62-dependent manner. Mol. Cell. Biol. 33, 2436-2446.
5. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y. S., Ueno, I., Sakamoto, A., Tong, K. I., Kim, M., Nishito, Y., Iemura, S., Natsume, T., Ueno, T., Kominami, E., Motohashi, H., Tanaka, K., and Yamamoto, M. (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223.
6. Jain, A., Lamark, T., Sjøttem, E., Larsen, K. B., Awuh, J. A., Øvervatn, A., McMahon, M., Hayes, J. D., and Johansen, T. (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576-22591.
7. Adams, J. M., and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337.
8. Junttila, M. R., and Evan, G. I. (2009) p53-a Jack of all trades but master of none. Nat. Rev. Cancer 9, 821-829.
9. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: The next generation. Cell 144, 646-674.
10. White, E., and DiPaola, R. S. (2009) The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 15, 5308-5316.
11. Levine, B., and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42.
12. Sporn, M. B., and Liby, K. T. (2012) NRF2 and cancer: The good, the bad and the importance of context. Nat. Rev. Cancer 12, 564-571.
13. Hayes, J. D., McMahon, M., Chowdhry, S., and Dinkova-Kostova, A. T. (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 13, 1713-1748.
14. Hu, R., Saw, C. L., Yu, R., and Kong, A. N. (2010) Regulation of NF-E2- related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid. Redox Signa. 13, 1679-1698.
15. Wang, X. J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., Wong, P. K., and Zhang, D. D. (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29, 1235-1243.
16. Chang, Q., Pan, J., Wang, X., Zhang, Z., Chen, F., and Shi, X. (2010) Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells. Cancer Res. 70, 5127-5135.
17. Son, Y. O., Wang, L., Poyil, P., Budhraja, A., Hitron, J. A., Zhang, Z., Lee, J. C., and Shi, X. (2012) Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3B/B-catenin signaling. Toxicol. Appl. Pharmacol. 264, 153-160.
18. Son, Y. O., Wang, X., Hitron, J. A., Zhang, Z., Cheng, S., Budhraja, A., Ding, S., Lee, J. C., and Shi, X. (2011) Cadmium induces autophagy through ROS-dependent activation of the LKB1-AMPK signaling in skin epidermal cells. Toxicol. Appl. Pharmacol. 255, 287-296.
19. Agency for Toxic Substances and Disease Registry (2013) Priority List of Hazardous Substances, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
20. Bode, A. M., and Dong, Z. (2002) The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol. Hematol. 42, 5-24.
21. Wickre, J. B., Folt, C. L., Sturup, S., and Karagas, M. R. (2004) Environmental exposure and fingernail analysis of arsenic and mercury in children and adults in a Nicaraguan gold mining community. Arch. Environ. Health 59, 400-409.
22. Hughes, M. F. (2002) Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133, 1-16.
23. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
24. Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H. Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., Dipaola, R. S., Karantza-Wadsworth, V., and White, E. (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075.
25. Lau, A., Wang, X. J., Zhao, F., Villeneuve, N. F., Wu, T., Jiang, T., Sun, Z., White, E., and Zhang, D. D. (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30, 3275-3285.
26. Maiuri, M. C., Zalckvar, E., Kimchi, A., and Kroemer, G. (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741-752.